Aims We compared beta-cell function in Chinese with type 2 diabetes diagnosed at age< 40
years (young-onset diabetes, YOD) and≥ 40 years (late-onset diabetes, LOD). Methods In …

The increasing incidence of type 2 diabetes, which represents 90% of diabetes cases
globally, is a major public health concern. Improved glucose management reduces the risk …

Diabetes mellitus (DM) is the most common metabolic disease in humans, and its
prevalence is increasing worldwide in parallel with the obesity pandemic. A lack of insulin or …

Introduction None of the studies of type 2 diabetes (T2D) subtyping to date have used linked
population-level data for incident and prevalent T2D, incorporating a diverse set of …

OBJECTIVE We evaluated baseline characteristics of participants with early-onset type 2
diabetes (T2D) from the SURPASS program and tirzepatide's effects on glycemic control …

Background Type 2 diabetes is associated with a variety of complications, including micro-
and macrovascular complications, neurological manifestations and poor wound healing …

Introduction. Childhood obesity is increasing worldwide and presents as a global health
issue due to multiple metabolic comorbidities. About 1% of adolescents with obesity develop …

Glipizide; an insulin secretagogue belonging to the sulfonylurea class, is a widely used
antidiabetic drug for managing type 2 diabetes. However, the need for life-long …

Obesity prevalence is becoming a serious global health and economic issue and is a major
risk factor for concomitant diseases that worsen the quality and duration of life. Therefore …

Introduction We designed and implemented a patient-centered, data-driven, holistic care
model with evaluation of its impacts on clinical outcomes in patients with young-onset type 2 …